Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,306
  • Shares Outstanding, K 4,499
  • Annual Sales, $ 6,160 K
  • Annual Income, $ -14,910 K
  • EBIT $ -10 M
  • EBITDA $ -10 M
  • 60-Month Beta -0.82
  • Price/Sales 2.45
  • Price/Cash Flow N/A
  • Price/Book 2.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.58 +101.27%
on 03/16/26
5.38 -40.89%
on 03/23/26
+1.06 (+50.00%)
since 03/13/26
3-Month
0.69 +358.87%
on 02/05/26
5.38 -40.89%
on 03/23/26
+1.93 (+154.40%)
since 01/13/26
52-Week
0.69 +358.87%
on 02/05/26
17.44 -81.77%
on 04/17/25
-13.02 (-80.37%)
since 04/11/25

Most Recent Stories

More News
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

Standard-of-care imaging and risk models indicated cancer after lung screening revealed 30-millimeter pulmonary nodule CyPath® Lung test affirmed physician’s...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16

Invitation-only conference focuses on the evolving landscape of lung cancer risk and early detection when the disease is most treatable bioAffinity Technologies...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

Noninvasive diagnostic continues to gain traction in the current and expanding U.S. addressable market of $3.58 billion for pulmonary nodule management and surveillance of lung cancer survivors ...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

Panel of leading pulmonologists will share real-world patient cases and benefits of clinical use of the noninvasive CyPath® Lung diagnostic test First...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

Panel of leading pulmonologists will share real-world patient cases and benefits of clinical use of the noninvasive CyPath® Lung diagnostic test First...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures

CyPath® Lung improves diagnostic clarity in patients with multiple lung nodules In this case study, CyPath® Lung “Unlikely Malignancy” result supported...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung

Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company’s high-value CyPath® Lung test Number...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patients Murtha Cancer Center Research Program...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients

Poster presented to medical and drug industry conferees at prestigious American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting Research...

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test

Validating sample collection by deep suction has potential to accelerate and expand adoption of CyPath® Lung

BIAF : 3.18 (-5.07%)
BIAFW : 0.3600 (-9.11%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 3.67
2nd Resistance Point 3.49
1st Resistance Point 3.33
Last Price 3.18
1st Support Level 3.00
2nd Support Level 2.82
3rd Support Level 2.66

See More

52-Week High 17.44
Fibonacci 61.8% 11.04
Fibonacci 50% 9.07
Fibonacci 38.2% 7.09
Last Price 3.18
52-Week Low 0.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.